| Financial Year |
March 31 2023 |
| Monetary Funds |
735,930,001.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
355,414,358.13 |
| Accounts Receivable |
934,694,236.39 |
| Advances to Suppliers |
18,045,953.56 |
| Other Receivables |
4,636,884.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,943,222.22 |
| Dividend Receivable |
-- |
| Inventories |
640,494,748.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,646,942.65 |
| Total Current Assets |
2,899,406,124.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
100,886,797.71 |
| Investment Properties |
-- |
| Fixed Assetes |
1,370,337,550.88 |
| Under-construction Projects |
227,526,731.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
287,482,644.03 |
| R&D expenses |
-- |
| Goodwill |
238,458,053.01 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
45,409,233.64 |
| Other Non-Current Assets |
18,199,465.88 |
| Sub-Total of Non-Current Assets |
2,293,553,233.37 |
| Total Assets |
5,192,959,357.74 |
| Short-Term Loans |
729,592,267.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
529,837,740.27 |
| Accounts Payable |
358,661,348.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,202,622.64 |
| Taxes Payable |
10,024,174.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,980,816.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
107,550,754.68 |
| Other Current Liabilities |
301,592,072.26 |
| Sub-Total of Current Liabilities |
2,105,672,482.06 |
| Long-term Loans |
318,950,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
49,100,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,203,294.35 |
| Deferred Income Tax Liabilities |
69,935,324.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
467,778,847.54 |
| Total Liabilities |
2,573,451,329.60 |
| Paid-In Capital(Or Share Stock) |
435,612,051.00 |
| Capital Surplus |
1,762,809,384.28 |
| Surplus Reserve |
26,290,062.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-127,365,431.22 |
| Minority Stockholder's Interest |
522,414,227.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,097,093,800.31 |
| Owner's Equity（Stockholder's Equity） |
2,619,508,028.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,192,959,357.74 |
